跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

BP528

Lormetazepam

British Pharmacopoeia (BP) Reference Standard

别名:

N-Methyllorazepam

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C16H12Cl2N2O2
CAS号:
848-75-9
分子量:
335.18
MDL编号:
MFCD00058578
UNSPSC代码:
41116107
NACRES:
NA.24

等级

pharmaceutical primary standard

API类

lormetazepam

制造商/商品名称

BP

drug control

psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

包装形式

neat

储存温度

2-8°C

SMILES字符串

Clc1c(cccc1)C2=NC(C(=O)N(c3c2cc(cc3)Cl)C)O

InChI

1S/C16H12Cl2N2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3

InChI key

FJIKWRGCXUCUIG-UHFFFAOYSA-N

相关类别

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Lormetazepam BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • SC VI A. Pharmacopoeial Calculations
  • Lormetazepam Tablets
  • Lormetazepam

    • 包装

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    其他说明

    Sales restrictions may apply.

    法规信息

    监管及禁止进口产品

    历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    抱歉，我们目前尚未线上提供该产品的COA。

    如需帮助，请联系 客户支持

    已有该产品？

    在文件库中查找您最近购买产品的文档。

    访问文档库

    A López-Rabuñal et al.
    Journal of analytical toxicology, 44(6), 580-588 (2020-02-18)
    An LC-MS-MS method for the determination of 14 benzodiazepines (BZDs) (alprazolam, α-hydroxyalprazolam, clonazepam, bromazepam, diazepam, nordiazepam, lorazepam, lormetazepam, oxazepam, flunitrazepam, 7-aminoflunitrazepam, triazolam, midazolam and zolpidem) and 15 antidepressants (ADs) (amitriptyline, nortriptyline, imipramine, desipramine, clomipramine, norclomipramine, fluoxetine, norfluoxetine, sertraline, norsertraline, paroxetine
    Satomi Kagota et al.
    European journal of pharmacology, 892, 173744-173744 (2020-11-22)
    Benzodiazepines (BDZs) and non-BDZ sedative-hypnotics are effective for the management of chronic insomnia; however, they are associated with adverse effects such as headache, dizziness, and palpitations. Furthermore, long-term use of these medications is associated with decreased blood pressure (BP) or
    Alicja Majda et al.
    Talanta, 209, 120533-120533 (2020-01-02)
    For the first time the method DI-SPME/LC-TOFMS was used and developed in order to determine the large antidepressant drugs in real forensic cases. The aim of the study was to optimize the new DI-SPME/LC-TOFMS method for the quantification of the

    我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系技术服务部门